The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells ; volume:23 ; number:1 ; day:6 ; month:1 ; year:2023 ; pages:1-14 ; date:12.2023
BMC cancer ; 23, Heft 1 (6.1.2023), 1-14, 12.2023
- Urheber
-
Bakadlag, Rowa
Limniatis, Georgia
Georges, Gabriel
Georges, Elias
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-10474-x
- URN
-
urn:nbn:de:101:1-2023031521360554016096
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bakadlag, Rowa
- Limniatis, Georgia
- Georges, Gabriel
- Georges, Elias
- SpringerLink (Online service)
Ähnliche Objekte (12)
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Tamoxifen
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection
A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Tamoxifen stimulates arachidonic acid release from rat liver cells by an estrogen receptor-independent, non-genomic mechanism
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Tamoxifen
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection
A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Tamoxifen stimulates arachidonic acid release from rat liver cells by an estrogen receptor-independent, non-genomic mechanism
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Tamoxifen
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection
A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer